New insight into the damaging impact of chronic cocaine or alcohol use on cognitive flexibility

FHS
July 12, 2023
5:37 am

An estimated 50 million individuals in the United States struggle with the challenges of cocaine or alcohol use disorders, according to the National Institutes of Health (NIH).

FDA grants ODD to NMD’s CMT disease therapy, NMD670

NMD670 is an oral therapy designed to treat Charcot-Marie-Tooth disease. Credit: SkazovD / Shutterstock. The US Food and Drug Administration (FDA) has granted orphan drug

January 6, 2025

Millions were booted from Medicaid. The insurers that run it gained Medicaid revenue anyway.

Private Medicaid health plans lost millions of members in the past year as pandemic protections that prohibited states from dropping anyone from the government program

April 26, 2024

Clearmind Medicine to Participate in Traditional vs. Novel Psychedelics Virtual Event with Leading Industry Figures | Psychedelic Invest

Clearmind Medicine CEO, Dr. Adi Zuloff-Shani, and MAPS founder and psychedelic sector pioneer, Rick Doblin, will discuss the growing and changing international psychedelic space Clearmind

November 28, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.